Dejar opinión sobre Grupo Simen Ciudad de México

Uscom Ltd today announced the appointment of Grupo SIM as regional distributor for Uscom Ltd products in Mexico. The Grupo SIM specialized subsidiary distributes medical products into intensive care, pulmonary and respiratory care, diagnostic cardiology, cardiac monitoring, critical care and neonatal and paediatric critical care units in Mexico. Mexico has a population of 115m and the Mexican medical device market was estimated to be $3. 4b US in 2012. This market is supported by a rapid population growth, increasing health expenditure, a high incidence of chronic diseases, and a commitment to acquisition of new technology in the public health sector. The improved economic outlook for the 2013 – 2017 period has further boosted growth prospects. The appointment is part of the execution of the third leg of the strategic restructure of Uscom articulated at last year’s AGM by the Uscom Board to develop and expand global product distribution following capital raising and operational consolidation. Sales and distribution are the critical next steps for Uscom commercialisation. Executive Chairman of Uscom, Rob Phillips said, “Distribution is the final piece in the commercialisation puzzle. We have validated and approved technology, established world leading and practice changing science, and our mission now is to establish an effective and penetrating network of distribution to deliver our products to market. Mexico is a huge and growing market, and Grupo SIM an excellent company. We are looking forward to working closely with Grupo SIM to realise the Mexican sales opportunity. We are intent on establishing an effective global network of distribution to provide the sales foundation on which to build a multi-product company of high profitability. ”